UB Paderborn / Katalog / Suche / in CDI

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer

Annals of oncology, 2009-10, Vol.20 (10), p.1639-1646

2009

Volltextzugriff (PDF)

Epidemiology and prognosis of ovarian metastases in colorectal cancer

British journal of surgery, 2010-11, Vol.97 (11), p.1704-1709

2010

Volltextzugriff (PDF)

Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer

Colorectal disease, 2009-09, Vol.11 (7), p.768-774

2009

Volltextzugriff (PDF)

An expression signature at diagnosis to estimate prostate cancer patients' overall survival

Prostate cancer and prostatic diseases, 2014-03, Vol.17 (1), p.81-90

2014

Volltextzugriff (PDF)

5182 POSTER Prognosis of Breast Cancer Patients – Causes of Death, Effect of Time Since Diagnosis, Age and Tumour Characteristics

European journal of cancer (1990), 2011, Vol.47, p.S385-S385

2011

Volltextzugriff (PDF)

Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics

Journal of clinical oncology, 2011-10, Vol.29 (30), p.4014-4021

2011

Volltextzugriff (PDF)

Age-specific trends of survival in metastatic breast cancer: Data from a population-based cancer registry in Stockholm, Sweden

JOURNAL OF CLINICAL ONCOLOGY, 2010, Vol.28 (15_suppl), p.1058-1058

2010

Volltextzugriff (PDF)

Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome

Annals of oncology, 2007-05, Vol.18 (5), p.845-850

2007

Volltextzugriff (PDF)

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial

The Lancet (British edition), 2011, Vol.378 (9803), p.1635-1642

2011

Volltextzugriff (PDF)

Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor

Medical oncology (Northwood, London, England), 2009-12, Vol.26 (4), p.480-490

2009

Volltextzugriff (PDF)

A Population-based Study on Outcome in Relation to the Type of Resection in Low Rectal Cancer

Diseases of the colon & rectum, 2010-05, Vol.53 (5), p.753-760

2010

Volltextzugriff (PDF)

Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden

Breast cancer research and treatment, 2011-11, Vol.130 (2), p.553-560

2011

Volltextzugriff (PDF)

Paget’s disease of the nipple in a population based cohort

Breast cancer research and treatment, 2008-09, Vol.111 (2), p.313-319

2008

Volltextzugriff (PDF)

Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden

European journal of cancer (1990), 2012-07, Vol.48 (11), p.1672-1681

2012

Volltextzugriff (PDF)

Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer: A National Survey

Annals of surgery, 2011, Vol.253 (6), p.1147-1154

2011

Volltextzugriff (PDF)

Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer

Breast cancer research and treatment, 2011-01, Vol.125 (2), p.457-465

2011

Volltextzugriff (PDF)

Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient management

Acta dermato-venereologica, 2013-01, Vol.93 (4), p.411-416

2013

Volltextzugriff (PDF)

Esophageal stricture after radiotherapy in patients with head and neck cancer: Experience of a single institution over 2 treatment periods

Head & neck, 2010-04, Vol.32 (4), p.452-461

2010

Volltextzugriff (PDF)

A gene expression signature to predicit overall, prostate cancer, and non–prostate cancer survival

JOURNAL OF CLINICAL ONCOLOGY, 2013, Vol.31 (6_suppl), p.51-51

2013

Volltextzugriff (PDF)

P1-06-19: Absence or Low Levels of c-JunNH2 – Terminal Protein Kinase (JNK) Mitogen Activated Protein Kinase (MAPK) Is Related to a Luminal B Subtype and an Impaired Survival in Patients with an ER Positive Breast Cancer Treated with Adjuvant Tamoxifen

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-06-19

2011

Volltextzugriff (PDF)

ProMIS™ can serve as a da Vinci® simulator--a construct validity study

Journal of endourology, 2011-02, Vol.25 (2), p.345

2011

Volltextzugriff (PDF)

Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen

European journal of cancer (1990), 2006-05, Vol.42 (8), p.1104-1112

2006

Volltextzugriff (PDF)

Abstract P6-10-03: Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer — A National Survey

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P6-P6-10-03

2010

Volltextzugriff (PDF)

400 HIGH PREVALENCE OF DISTANT METASTASES AND LOCALLY ADVANCED GROWTH ALSO IN SMALL RENAL CELL CARCINOMAS

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (2), p.140-140

2011

Volltextzugriff (PDF)

P104 Expressions of biomarkers to predict overall and cancer-specific survival of prostate cancer

European urology supplements : official journal of the European Association of Urology, 2012-11, Vol.11 (5), p.226-226

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer

Epidemiology and prognosis of ovarian metastases in colorectal cancer

Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer

An expression signature at diagnosis to estimate prostate cancer patients' overall survival

5182 POSTER Prognosis of Breast Cancer Patients – Causes of Death, Effect of Time Since Diagnosis, Age and Tumour Characteristics

Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics

Age-specific trends of survival in metastatic breast cancer: Data from a population-based cancer registry in Stockholm, Sweden

Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial

Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor

A Population-based Study on Outcome in Relation to the Type of Resection in Low Rectal Cancer

Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden

Paget’s disease of the nipple in a population based cohort

Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden

Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer: A National Survey

Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer

Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient management

Esophageal stricture after radiotherapy in patients with head and neck cancer: Experience of a single institution over 2 treatment periods

A gene expression signature to predicit overall, prostate cancer, and non–prostate cancer survival

P1-06-19: Absence or Low Levels of c-JunNH2 – Terminal Protein Kinase (JNK) Mitogen Activated Protein Kinase (MAPK) Is Related to a Luminal B Subtype and an Impaired Survival in Patients with an ER Positive Breast Cancer Treated with Adjuvant Tamoxifen

ProMIS™ can serve as a da Vinci® simulator--a construct validity study

Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen

Abstract P6-10-03: Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer — A National Survey

400 HIGH PREVALENCE OF DISTANT METASTASES AND LOCALLY ADVANCED GROWTH ALSO IN SMALL RENAL CELL CARCINOMAS

P104 Expressions of biomarkers to predict overall and cancer-specific survival of prostate cancer

Suchergebnisse filtern